"Mycobacterium bovis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.
| Descriptor ID |
D009163
|
| MeSH Number(s) |
B03.510.024.049.525.500.402 B03.510.460.400.410.552.552.402
|
| Concept/Terms |
BCG- BCG
- Calmette-Guerin Bacillus
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium bovis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium bovis".
This graph shows the total number of publications written about "Mycobacterium bovis" by people in this website by year, and whether "Mycobacterium bovis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium bovis" by people in Profiles.
-
Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596. Eur Urol Oncol. 2024 Apr; 7(2):301.
-
Bacillus Calmette-Gu?rin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal? BJU Int. 2023 10; 132(4):384-386.
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
-
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Gu?rin Response in High-Grade Ta Tumors. J Urol. 2022 08; 208(2):284-291.
-
Pathogenesis of tuberculosis: the 1930 L?beck disaster revisited. Eur Respir Rev. 2022 Jun 30; 31(164).
-
Plasma Metagenomic Sequencing Expedites Diagnosis of Disseminated BCG in an Infant With IKBKB Mutation. Pediatr Infect Dis J. 2022 05 01; 41(5):430-435.
-
Reduced-dose bacillus Calmette-Gu?rin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre. BJU Int. 2022 09; 130(3):323-330.
-
Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics. 2021 12 01; 148(6).
-
100 years of Mycobacterium bovis bacille Calmette-Gu?rin. Lancet Infect Dis. 2022 01; 22(1):e2-e12.
-
Successful SCID gene therapy in infant with disseminated BCG. J Allergy Clin Immunol Pract. 2021 02; 9(2):993-995.e1.